Le transfert des connaissances et la mise en œuvre de lignes directrices de pratique Expérience du Programme d’Éducation Canadien sur l’Hypertension

Abstract

For the last 10 years, the update of guidelines for the treatment of hypertension in Canada is part of an annual process. This national strategy called the Canadian Hypertension Education Program (CHEP) has an organizational structure which allows not only to revise guidelines using an evidence-based scientific process but also to facilitate the implementation and the dissemination of the recommendations to the various healthcare professionals (doctors, pharmacists, nurses, etc.). As part of this process, the CHEP is also measuring different outcomes which could estimate the impact of its interventions. Recent data clearly show an improvement of the screening of hypertension as well as the quality of antihypertensive treatment (increase in the number of new prescriptions and of the percentage of subjects treated with 2 antihypertensive agents or more) in Canada. Finally, recent Canadian data showing a reduction of the cardiovascular complications attributable to hypertension suggest a possible link of causality with the implementation of the CHEP. This article will describe the functioning of the CHEP with its various strategies aiming at a better management of hypertension in Canada.